This article was originally published in The Gray Sheet
Launches the GEM DR model 7271 full-featured, dual chamber, rate responsive pacemaker/defibrillator system in Europe. The device incorporates Active Can technology as well as Medtronic's PR Logic dual chamber detection algorithm to discriminate between fast ventricular rhythms that are life-threatening and fast atrial arrhythmias that are not. At 62 cc, the 35 joule GEM DR is the world's smallest defibrillator and is anticipated to last seven to nine years under typical use conditions. A May 8 premarket approval application submission is pending at FDA for the device
You may also be interested in...
Sandoz announced more than a year ago that its GP2411 biosimilar denosumab candidate had entered the clinic. Management provided an update on its progress at the recent Virtual Meet Novartis Management Investor Event.
Dr Reddy's is poised to expand its OTC offering in Russia and certain CIS countries by snapping up a basket of allergy brands from fellow Indian firm Glenmark.
Sandoz has launched an awareness campaign under the banner of “Ask For Generics” in the US. The initiative is aiming to educate stakeholders on the benefits of generics and their quality, safety and efficacy.